Schedule 13G filing

AdvisorShares Trust cut its Quantum Biopharma Ltd. (QNTM) stake below 5%

Schedule 13G · Filed Oct 5, 2026

AdvisorShares Trust reported owning 5% of Quantum Biopharma Ltd. (QNTM) (400,378 shares) in a Schedule 13G filed Oct 5, 2026.

A 13G is a passive stake: the holder does not plan to push for changes.

Exited

Quantum Biopharma Ltd.

Stake

5% stake

Share this trade

From a public Schedule 13G, linked above. Not investment advice, and not a recommendation to buy or sell.